Seems like Jaguar is preparing for Mytesi to be used on a wider scale by making it easier to use the drug for patients and physicians....I take that as a good sign that phase III will have FDA approval.
"We remain committed to reducing access and reimbursement barriers for Mytesi patients."
Jaguar Health, Inc. (Nasdaq:JAGX) ("Jaguar" or the "Company") today announced that the Company is developing an artificial intelligence-powered web portal for U.S. healthcare professionals to support patient access to Mytesi (crofelemer), the Company's FDA-approved antidiarrheal prescription drug indicated for the symptomatic relief of noninfectious diarrhea in adult patients with HIV/AIDS on antiretroviral therapy.
That's definitely not you. Lisa must be getting to you. She made such an error in that British interview the editor had to correct her in print. Not quite sure what this woman is on but is that what's got you all out of sorts? Easy now, been there, feel your pain. They haven't figured out a pill for it yet, so be careful.
Market Data 
Markets 
AI
